Results 271 to 280 of about 4,376,632 (304)
Some of the next articles are maybe not open access.
Label-Free Functional Selectivity Assays
2015G protein-coupled receptors (GPCRs) represent the largest class of drug targets. Ligand-directed functional selectivity or biased agonism opens new possibility for discovering GPCR drugs with better efficacy and safety profiles. However, quantification of ligand bias is challenging.
Ann M, Ferrie +3 more
openaire +2 more sources
Label‐Free Technologies for Drug Discovery
2011Over the past two decades the benefits of label-free biosensor analysis have begun to make an impact in the market, and systems are beginning to be used as mainstream research tools in many drug discovery laboratories. Label-Free Technologies For Drug Discovery summarises the latest and emerging developments in label-free detection systems, their ...
Cooper, Matthew, Mayr, Lorenz M.
openaire +3 more sources
Functional blood cell analysis by label-free biosensors and single-cell technologies
Advances in Colloid and Interface Science, 2022Beatrix Peter +2 more
exaly
Can the Part Replace the Whole? A Choice Experiment on Organic and Pesticide-Free Labels
Foods, 2022Qiuqin Zheng, Qiuhua Chen, Xiaoke Yang
exaly
Less label, more free: Approaches in label-free quantitative mass spectrometry
Proteomics, 2011Albert Lee +2 more
exaly
Encoded Porous Beads for Label-Free Multiplex Detection of Tumor Markers
Advanced Materials, 2009Zhongze Gu, Yuan Jin Zhao, Xiangwei Zhao
exaly
Ultra-Sensitive Graphene-Plasmonic Hybrid Platform for Label-Free Detection
Advanced Materials, 2013Owen Liang +2 more
exaly

